Anais Malpica

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. pmc Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies
    Kai Erik Uleberg
    Pathology Department, Stavanger University Hospital, Armauer Hansen Road 20, Stavanger, Norway
    Proteome Sci 9:36. 2011
  2. ncbi request reprint Grading ovarian serous carcinoma using a two-tier system
    Anais Malpica
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 28:496-504. 2004
  3. doi request reprint Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases
    Anais Malpica
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Am J Surg Pathol 36:117-27. 2012
  4. doi request reprint Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary
    Anais Malpica
    Departments of Pathology and Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Gynecol Pathol 30:613-9. 2011
  5. doi request reprint Grading of ovarian cancer: a histotype-specific approach
    Anais Malpica
    Department of Pathology, The University of Texas M D Anderson Cancer, Houston, Texas 77030, USA
    Int J Gynecol Pathol 27:175-81. 2008
  6. ncbi request reprint Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis
    Kwong Kwok Wong
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 26:404-9. 2007
  7. ncbi request reprint Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, 1155 Herman Pressler Drive, Houston, TX 77030, USA
    Gynecol Oncol 108:510-4. 2008
  8. ncbi request reprint Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas
    Koushan Siami
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Am J Surg Pathol 31:1759-63. 2007
  9. ncbi request reprint Malignant melanoma involving the ovary: a clinicopathologic and immunohistochemical study of 23 cases
    Deepali Gupta
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 28:771-80. 2004
  10. pmc BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas
    Kwong Kwok Wong
    Departments of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Am J Pathol 177:1611-7. 2010

Detail Information

Publications96

  1. pmc Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies
    Kai Erik Uleberg
    Pathology Department, Stavanger University Hospital, Armauer Hansen Road 20, Stavanger, Norway
    Proteome Sci 9:36. 2011
    ..abstract:..
  2. ncbi request reprint Grading ovarian serous carcinoma using a two-tier system
    Anais Malpica
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 28:496-504. 2004
    ..However, additional studies are required to validate these statements...
  3. doi request reprint Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases
    Anais Malpica
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Am J Surg Pathol 36:117-27. 2012
    ..Although no patient died of disease in this series, follow-up of patients with this diagnosis is warranted on the basis of possible recurrences or misdiagnosis of an undersampled malignant mesothelioma...
  4. doi request reprint Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary
    Anais Malpica
    Departments of Pathology and Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Gynecol Pathol 30:613-9. 2011
    ..This case underscores the importance of attentive histopathologic examination and the use of ancillary tests to ensure the recognition of the site of origin of a neoplasm involving the cervix...
  5. doi request reprint Grading of ovarian cancer: a histotype-specific approach
    Anais Malpica
    Department of Pathology, The University of Texas M D Anderson Cancer, Houston, Texas 77030, USA
    Int J Gynecol Pathol 27:175-81. 2008
    ..In this article, this histotype-specific approach to the grading of ovarian carcinoma is discussed...
  6. ncbi request reprint Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis
    Kwong Kwok Wong
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 26:404-9. 2007
    ..These differences may lead to the development of different therapeutic strategies for women with either the low-grade or the high-grade form of OSC...
  7. ncbi request reprint Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, 1155 Herman Pressler Drive, Houston, TX 77030, USA
    Gynecol Oncol 108:510-4. 2008
    ..To evaluate the response of women with low-grade serous carcinoma of the ovary or peritoneum to platinum-based neoadjuvant chemotherapy...
  8. ncbi request reprint Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas
    Koushan Siami
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Am J Surg Pathol 31:1759-63. 2007
    ..It should also be taken into consideration in the evaluation of adenocarcinomas involving the lung in patients with a history of a gynecologic malignancy...
  9. ncbi request reprint Malignant melanoma involving the ovary: a clinicopathologic and immunohistochemical study of 23 cases
    Deepali Gupta
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 28:771-80. 2004
    ..S-100 is the most sensitive marker. MART-1 was positive in the few cases that were negative with HMB-45. Inhibin can be focally positive in some cases...
  10. pmc BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas
    Kwong Kwok Wong
    Departments of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Am J Pathol 177:1611-7. 2010
    ..In addition, advanced-stage, low-grade carcinoma patients with BRAF or KRAS mutation have a better apparent clinical outcome. However, further investigation is needed...
  11. ncbi request reprint Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary
    David M Gershenson
    Department of Gynecologic Oncology and Pathology, The University of Texas M D Anderson Cancer Center, Houston, 77230 1439, USA
    Obstet Gynecol 108:361-8. 2006
    ..To analyze the clinical behavior of patients with stage II-IV low-grade serous carcinoma of the ovary seen at our institution who underwent primary surgery followed by platinum-based chemotherapy...
  12. ncbi request reprint Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma
    Hyun S Shvartsman
    Department of Gynecologic Oncology, Unit 1362, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1439, USA
    Gynecol Oncol 105:625-9. 2007
    ..The purpose of this study was to compare the outcomes of patients with these two tumor types...
  13. pmc The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer
    Erin R King
    Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Am J Surg Pathol 35:904-12. 2011
    ..The progression of SBOT to LG serous ovarian carcinoma may involve the dedifferentiation of ciliated cells. AGR3 could serve as a prognostic marker for survival in patients with LG and HG serous ovarian carcinomas...
  14. doi request reprint Thyroid transcription factor-1 expression in ovarian epithelial neoplasms
    Lena A Kubba
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Mod Pathol 21:485-90. 2008
    ..It should also be taken into consideration when evaluating adenocarcinomas involving the lung in patients with a history of a gynecologic malignancy...
  15. ncbi request reprint Classification using the cumulative log-odds in the quantitative pathologic diagnosis of adenocarcinoma of the cervix
    Richard J Swartz
    Department of Behavioral Science, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd Unit 243, Houston, TX 77098, USA
    Gynecol Oncol 99:S24-31. 2005
    ..This study develops a method that discriminates between normal and cancerous tissue sections (i.e., populations of cells) using a statistical model applied to high-dimensional quantitative measurements made on a sample of cells...
  16. ncbi request reprint Cervical chromosome 9 polysomy: validation and use as a surrogate endpoint biomarker in a 4-HPR chemoprevention trial
    Heung Gon Kim
    Department of Cellular and Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 99:S32-7. 2005
    ..Chromosomal instability is a feature of most human cancers and is probably an early event in the process...
  17. ncbi request reprint Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma
    Wareef Kabbani
    Department of Pathalogy, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 22:297-302. 2003
    ....
  18. pmc Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy
    Scott B Cantor
    Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Int J Cancer 128:1151-68. 2011
    ..Alternative statistical approaches demonstrate that the analysis is robust and that spectroscopy works as well as or slightly better than colposcopy for the detection of CIN 2 to cancer...
  19. ncbi request reprint Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin
    Michael T Deavers
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Mod Pathol 16:584-90. 2003
    ..Finally, these results demonstrate that calretinin is at least as sensitive as inhibin for ovarian SCSTs overall and that it is more sensitive than inhibin for fibromas and FTs...
  20. doi request reprint Primary peritoneal serous carcinoma presenting as inflammatory breast cancer
    Ibrahim Khalifeh
    Department of Pathology, MD Anderson Cancer Center, Houston, Texas, USA
    Breast J 15:176-81. 2009
    ..To our knowledge, this is the first reported case of an extramammary primary malignancy that not only presented as inflammatory breast cancer but also was diagnosed and initially treated as such...
  21. ncbi request reprint Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases
    Lisa K Culton
    Department of Pathology, The University of Texas Medical School at Houston, Houston, TX, USA
    Am J Surg Pathol 30:844-9. 2006
    ..The tumors are predominantly well or moderately differentiated with dissimilar endometrial and FT grades. The FT carcinoma is usually unilateral and located at the distal end of the tube...
  22. ncbi request reprint Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases
    Emanuela Veras
    Department of Pathology, The University of Texas Medical School at Houston, Houston, TX 77030, USA
    Am J Surg Pathol 31:774-82. 2007
    ....
  23. pmc Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment
    Jingfang Zheng
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Cell Cycle 9:140-6. 2010
    ....
  24. ncbi request reprint The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent
    Elvio G Silva
    Department of Pathology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 30:1367-71. 2006
    ..We propose that patients be followed for a minimum of 10 years to evaluate for recurrences and for 20 years to evaluate for survival...
  25. ncbi request reprint Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?
    Elvio G Silva
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 25:52-8. 2006
    ..In asynchronous cases, being aware of this association can explain the absence of a second primary...
  26. doi request reprint Low-grade smooth muscle tumors of the primary and the secondary mullerian system: a proposed concept of multicentricity
    Lorena Posligua
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Gynecol Pathol 31:547-55. 2012
    ..On the basis of these differences, the possibility that the extrauterine lesions in the low-grade group represent independent primaries involving the secondary mullerian system is proposed...
  27. doi request reprint Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study
    Emanuela Veras
    Department of Pathology, The University of Texas Medical School at Houston, Texas 77030, USA
    Int J Gynecol Pathol 28:316-21. 2009
    ....
  28. ncbi request reprint Calcifications in ovary and endometrium and their neoplasms
    Elvio G Silva
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Mod Pathol 16:219-22. 2003
    ..This is most probably secondary to metabolic changes, which could be related to hormones and not caused by degenerative changes in epithelial cells...
  29. ncbi request reprint Undifferentiated carcinoma of the endometrium
    Basel Altrabulsi
    Department of Pathology, Baylor University, 1515 Holcombe Boulevard, Dallas, TX 77030, USA
    Am J Surg Pathol 29:1316-21. 2005
    ..In summary, undifferentiated carcinoma of the endometrium appears to be more aggressive than endometrial endometrioid adenocarcinoma, FIGO grade 3. Its proper recognition is important for prognosis and potentially for therapy...
  30. doi request reprint Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis
    Saketh R Guntupalli
    Division of Gynecologic Oncology, Baylor College of Medicine, Houston, TX, USA
    Gynecol Oncol 113:324-6. 2009
    ..This retrospective study was designed to evaluate the clinicopathologic features and outcomes of a cohort of patients diagnosed with uterine smooth muscle tumor of uncertain malignant potential (STUMP) seen at a single institution...
  31. ncbi request reprint Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma
    Elizabeth D Euscher
    Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 32:1336-43. 2008
    ..25%. Negative SLN predicts negative non-SLN. For most patients with a positive SLN, the SLN will be the only metastasis detected; a minority of patients with a positive SLN may have a positive non-SLN...
  32. pmc The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
    Erin R King
    Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 123:13-8. 2011
    ..To validate the overexpression of insulin-like growth factor 1 (IGF-1) and its receptor (IGF-1R) in low-grade serous ovarian carcinoma (SOC), and to investigate whether the IGF-1 pathway is a potential therapeutic target for low-grade SOC...
  33. ncbi request reprint Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps
    Elizabeth D Euscher
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 29:1074-8. 2005
    ..Additionally, the difference in WT-1 expression between peritoneal serous carcinomas with and without coexistent serous carcinoma in endometrial polyps suggests that peritoneal serous carcinoma may have different pathogenetic pathways...
  34. ncbi request reprint KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma
    Yvonne T Tsang
    Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA
    J Pathol 231:449-56. 2013
    ..In summary, KRAS mutations are very common in recurrent LGSC, while BRAF mutations are rare. The findings indicate that recurrent LGSC can arise from proliferation of OSBT tumour cells with or without detectable KRAS mutations...
  35. ncbi request reprint Quantitative histopathology and chromosome 9 polysomy in a clinical trial of 4-HPR
    Jose Miguel Yamal
    Center for Biomedical Engineering, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Gynecol Oncol 94:296-306. 2004
    ..Quantitative pathology and chromosome 9 polysomy were used to understand the biology and quantify the clinical histopathologic changes observed...
  36. ncbi request reprint Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium
    Rosemarie E Schmandt
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 98:758-64. 2003
    ..Immunohistochemical expression of c-ABL, PDGFR-beta, and c-KIT was evaluated in ovarian carcinomas to determine whether treatment with imatinib mesylate might be feasible...
  37. ncbi request reprint Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa
    Elvio G Silva
    Department of Pathology, Box 85, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Am J Surg Pathol 28:244-9. 2004
    ..In uterine smooth muscle tumors, some epithelioid cells most likely undergo clear cell changes and become positive for HMB-45. It would be advisable to perform this stain in all epithelioid smooth muscle tumors of the uterus...
  38. doi request reprint Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study
    Diane C Bodurka
    The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 118:3087-94. 2012
    ....
  39. ncbi request reprint In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues
    Atac Baykal
    Department of Pathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Oncol Rep 11:297-302. 2004
    ..We conclude that human telomerase reverse transcriptase mRNA expression does not seem to be a reliable marker for clinical use in differentiating between benign and malignant tumors...
  40. ncbi request reprint Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases
    Michael T Deavers
    Department of Pathology and Gynecologic Oncology, University of Texas, Anderson Cancer Center, Houston, Texas 77030, USA
    Am J Surg Pathol 26:1129-41. 2002
    ..Additionally, our long-term follow-up of patients with typical SLMP indicates that a number of these tumors do not follow a benign course and supports their continued designation as borderline neoplasms...
  41. doi request reprint Dermatofibrosarcoma protuberans of the vulva: a clinicopathologic and immunohistochemical study of 13 cases
    Marcia Edelweiss
    Department of Pathology at the University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 34:393-400. 2010
    ..The frequent expression of PDGFR-alpha, PDGFR-beta, and c-abl in these cases agrees with the findings of other investigators and supports the use of imatinib (Gleevec) in cases that are recurrent or not amenable to surgery...
  42. ncbi request reprint Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma
    Anais Malpica
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 31:1168-74. 2007
    ....
  43. doi request reprint Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries
    Liuyan Jiang
    Department of Pathology, National Cancer Institute, Bethesda, MD, USA
    Int J Gynecol Pathol 29:146-56. 2010
    ..HPV studies are important to identify endocervical tumors associated with high-risk HPV. However, endometrial tumors involving the cervix and endocervical tumors unrelated to HPV are both negative for high-risk HPV...
  44. ncbi request reprint The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas
    Preetha Ramalingam
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Am J Surg Pathol 28:1499-505. 2004
    ..CK7 and EMA are essentially negative in YST but are diffusely positive in CCC and EAC, making them useful markers for differentiating YSTs from both CCCs and EACs. Leu-M1 may also be helpful for distinguishing YSTs from CCCs...
  45. doi request reprint Immunohistochemical studies of trophoblastic tumors
    Neda Kalhor
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 33:633-8. 2009
    ..However, the distinction of ITTs from choriocarcinoma cannot be accomplished on immunohistochemical studies, as they have similar immunophenotypes...
  46. ncbi request reprint Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall
    Monica A Recine
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 28:1646-51. 2004
    ..Clinical history, the presence of papillary architecture, and WT-1 expression are useful in establishing the correct diagnosis...
  47. doi request reprint The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium
    Suad H Taraif
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Texas 77030, USA
    Int J Gynecol Pathol 28:142-7. 2009
    ..In most cases, NE expression is only focally present (< or =10% of the cells). There is no difference in overall survival in patients with or without NE expression...
  48. ncbi request reprint Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3
    Anne Therese Vlastos
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 11:390-6. 2005
    ..125, 0.5 gm/m2, versus placebo in the treatment of cervical intraepithelial neoplasia (CIN) grades 2 to 3. A promising phase I study has shown histopathologic responses at these dose levels...
  49. ncbi request reprint Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions
    Bang Ning Lee
    Department of Hematopathology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:999-1007. 2006
    ..In the current study the functions of dendritic cells in the development of T-cell immunity in women with cervical SILs were assessed...
  50. ncbi request reprint The 2 stromal compartments of the normal cervix with distinct immunophenotypic and histomorphologic features
    Elaine Kling
    University of Texas MD Anderson Cancer Center, Houston, USA
    Ann Diagn Pathol 16:315-22. 2012
    ..Desmin+/SMA, calponin, caldesmon, myogenin, myoD1, CD34- cells could represent unusual myofibroblasts that should not be confused with a neoplastic process, especially if a mass is not present...
  51. doi request reprint Angiosarcoma arising in mature cystic teratoma of the ovary: a case report and review of the literature
    Alejandro Luina Contreras
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Gynecol Pathol 28:453-7. 2009
    ..To date, only 5 cases of angiosarcoma arising in a mature cystic teratoma of the ovary have been reported. Herein, we report the clinicopathologic features of one such case. A review of the literature is also presented...
  52. doi request reprint Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature
    Elizabeth D Euscher
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 32:219-28. 2008
    ....
  53. pmc PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas
    Celestine S Tung
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 22:1243-50. 2009
    ....
  54. ncbi request reprint Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall
    Michael R Lewis
    Department of Pathology, Given Bldg, The University of Vermont College of Medicine, 89 Beaumont Avenue, Burlington, VT 05405, USA
    Gynecol Oncol 105:395-8. 2007
    ....
  55. ncbi request reprint Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status
    Ravindranauth N Sawh
    Division of Pathology and Laboratory Medicine, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Hum Pathol 34:369-74. 2003
    ..Hum Pathol 34:369-374...
  56. ncbi request reprint Serous carcinoma of the ovary, fallopian tube, or peritoneum presenting as lymphadenopathy
    Elizabeth D Euscher
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 28:1217-23. 2004
    ..Patients with minimal peritoneal disease and extra-abdominal lymph node metastases survive longer than those with bulky peritoneal disease..
  57. doi request reprint Nodal endosalpingiosis in ovarian serous tumors of low malignant potential with lymph node involvement: a case for a precursor lesion
    Bojana Djordjevic
    Departments of Pathology, The University of Texas MD Anderson Cancer Center, USA
    Am J Surg Pathol 34:1442-8. 2010
    ..This result contributes to the understanding of the pathogenesis of extraovarian disease in cases of OSLMP and has important implications for patient management and follow-up...
  58. ncbi request reprint Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge
    Michael R Lewis
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 30:177-84. 2006
    ..Metastatic colorectal adenocarcinoma should be considered in the differential diagnosis of an ovarian mass, even if the mass is large and unilateral or in a young patient, to secure proper treatment of these patients...
  59. doi request reprint Low-grade serous primary peritoneal carcinoma
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, 1155 Herman Pressler Drive, Houston, TX 77230, USA
    Gynecol Oncol 121:482-6. 2011
    ..To further explore this issue, a retrospective analysis of the clinical and pathologic characteristics of women with low-grade serous PPC was performed...
  60. ncbi request reprint Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer
    Michael Frumovitz
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 92:205-10. 2004
    ..To evaluate patients with vulvar cancer who experienced a recurrence after undergoing lymphatic mapping and sentinel lymph node (SLN) biopsy...
  61. ncbi request reprint Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin
    Michael T Deavers
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 22:162-7. 2003
    ..MART-1 (Ab3) immunostaining may be useful for cases in which melanoma is considered in the differential diagnosis...
  62. doi request reprint Combined large cell neuroendocrine carcinoma and papillary serous carcinoma of the endometrium with pagetoid spread
    Lorena Posligua
    Departments of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Arch Pathol Lab Med 132:1821-4. 2008
    ..This component was diffusely positive for neuroendocrine markers. Following surgery, the patient was treated with radiation therapy and chemotherapy. She was without evidence of progression at 5 months of follow-up...
  63. doi request reprint Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Andres G Chiesa
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 29:108-12. 2010
    ..Caution dictates retaining the current nomenclature to ensure the follow-up of patients affected by this disease until uncertainty regarding the extent of sampling needed to exclude the presence of carcinoma is resolved...
  64. doi request reprint Unmasking the complexities of mucinous ovarian carcinoma
    Michael Frumovitz
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 117:491-6. 2010
    ..The objective of our review was to identify and synthesize the most current information on mucinous ovarian carcinoma with regard to pathologic, molecular, and clinical distinctions...
  65. doi request reprint Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases
    Bojana Djordjevic
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Am J Surg Pathol 34:1-9. 2010
    ..Grossly unremarkable lymph nodes are not at a decreased risk of LNI. The pattern and the greatest linear dimension of LNI foci were not shown to have prognostic significance...
  66. doi request reprint Safety and feasibility of robotic radical trachelectomy in patients with early-stage cervical cancer
    Pedro T Ramirez
    Department of Gynecologic Oncology, Unit 440, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 116:512-5. 2010
    ..This study aimed to determine the safety and feasibility of robotic radical trachelectomy and bilateral pelvic lymphadenectomy. We also describe our surgical technique...
  67. ncbi request reprint Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: qualitative histopathologic analysis and methodologic issues
    Anais Malpica
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 99:S38-52. 2005
    ....
  68. ncbi request reprint beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma
    Christine M Lee
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, TX 77030, Houston, USA
    Gynecol Oncol 88:363-8. 2003
    ..beta-Catenin has been previously associated with oncogenic activity in human cancers. We evaluated whether beta-catenin also plays a role in papillary serous ovarian neoplasms...
  69. doi request reprint Lymph node counts in endometrial cancer: expectations versus reality
    Elizabeth D Euscher
    Department of Pathology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Am J Surg Pathol 35:913-8. 2011
    ..Additional studies are required to determine the actual numbers of PLNs and PALNs present and to determine whether a revision of the number of LNs required to consider a lymphadenectomy as adequate is necessary...
  70. ncbi request reprint Validation of tissue microarray technology in ovarian carcinoma
    Daniel G Rosen
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4095, USA
    Mod Pathol 17:790-7. 2004
    ....
  71. ncbi request reprint Peritoneal lesions in guinea pigs treated with hormones
    Elvio G Silva
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA
    Int J Gynecol Pathol 21:412-5. 2002
    ..This finding is relevant to understanding the pathogenesis of both fibrous lesions associated with ovarian tumors and peritoneal leiomyomatosis...
  72. doi request reprint Patterns of low-grade serous carcinoma with emphasis on the nonepithelial-lined spaces pattern of invasion and the disorganized orphan papillae
    Elvio G Silva
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Gynecol Pathol 29:507-12. 2010
    ..In 62% of the cases, in addition to obvious areas of invasion, there were 2 patterns difficult to recognize as invasive, disorganized orphan papillae, and irregular well-developed glands...
  73. ncbi request reprint Undifferentiated carcinoma of the endometrium: a review
    Elvio G Silva
    Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Pathology 39:134-8. 2007
    ....
  74. pmc Depressed type 1 cytokine synthesis by superantigen-activated CD4+ T cells of women with human papillomavirus-related high-grade squamous intraepithelial lesions
    Bang Ning Lee
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Diagn Lab Immunol 11:239-44. 2004
    ....
  75. ncbi request reprint Use of a vacuum-assisted closure device in the treatment of recurrent Paget's disease of the vulva
    Hyun S Shvartsman
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Obstet Gynecol 102:1163-6. 2003
    ..Paget's disease of the vulva is a rare malignancy for which common recurrence is related to inadequate surgical margins. Excision with adequate surgical margins might leave a large defect that does not readily heal...
  76. ncbi request reprint Wolffian duct tumors: case reports and review of the literature
    Pedro T Ramirez
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Gynecol Oncol 86:225-30. 2002
    ..Although generally considered a tumor of low malignant potential, these tumors can recur. Two cases are reported here...
  77. ncbi request reprint Metastatic melanoma to the vagina: clinicopathologic and immunohistochemical study of three cases and literature review
    Deepali Gupta
    Department of Pathology and Laboratory Medicine, University of Texas Houston Health Science Center, Houston, Texas, USA
    Int J Gynecol Pathol 22:136-40. 2003
    ..One patient underwent wide local excision of tumor followed by chemotherapy, one patient had intracavitary radiotherapy, and one had palliative radiotherapy to the brain only. The patients died after a follow-up of 3, 14, and 48 months...
  78. ncbi request reprint Light scattering from cervical cells throughout neoplastic progression: influence of nuclear morphology, DNA content, and chromatin texture
    Rebekah Drezek
    Rice University, Bioengineering Department, Houston, Texas 77251, USA
    J Biomed Opt 8:7-16. 2003
    ..Understanding the quantitative relationships between nuclear features and scattering properties will aid in the development of noninvasive optical technologies for detection of precancerous conditions...
  79. ncbi request reprint Endometrial endometrioid adenocarcinoma in a premenopausal woman presenting with metastasis to bone: a case report and review of the literature
    Antonio G Neto
    Department of Pathology, University of Texas Medical School, Houston 77030, USA
    Int J Gynecol Pathol 21:281-4. 2002
    ..One month later, she underwent an ischial resection followed by radiotherapy. After a follow-up of 3 years, the patient shows no evidence of disease...
  80. ncbi request reprint Gross deciduosis peritonei obstructing labor: a case report and review of the literature
    Anais Malpica
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Gynecol Pathol 21:273-5. 2002
    ..After a postpartum visit at 5 weeks, the patient was lost to follow-up...
  81. ncbi request reprint Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives
    Debra A Bell
    Department of Pathology, Massachusetts General Hospital, Boston 02114 2696, USA
    Hum Pathol 35:934-48. 2004
    ....
  82. ncbi request reprint Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma
    Duc Thanh Le
    Departments of Gynecologic Medical Oncology, General Surgery, and Pathology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer Invest 21:682-9. 2003
    ..There were no grade > or = 3 hematologic toxicities. The combination of cisplatin and CPT-11 is well tolerated and has clinical benefits in patients with peritoneal mesothelioma...
  83. ncbi request reprint The role of hMSH3 and hMSH6 in ovarian endometrioid carcinoma and relationship with microsatellite instability phenotype
    Constance T Albarracin
    The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Oncol Rep 12:1217-9. 2004
    ..These results indicate that mutations in the mono-nucleotide tracts of hMSH3 and hMSH6 are infrequent in ovarian endometrioid adenocarcinomas, other mechanisms may play a more important role in the development of these tumors...
  84. ncbi request reprint Quantitative histopathological analysis of cervical intra-epithelial neoplasia sections: methodological issues
    Martial Guillaud
    Dept of Cancer Imaging, BC Cancer Agency, Vancouver, BC, Canada
    Cell Oncol 26:31-43. 2004
    ....
  85. ncbi request reprint Vaginal melanoma: a clinicopathologic and immunohistochemical study of 26 cases
    Deepali Gupta
    University of Texas Houston Health Science Center, USA
    Am J Surg Pathol 26:1450-7. 2002
    ..S-100 remains the most sensitive marker for these tumors. HMB-45 is negative in 23% cases of vaginal melanoma. Tyrosinase and MART-1 are useful markers when S-100 is negative or only focally positive...
  86. ncbi request reprint Optimal excitation wavelengths for discrimination of cervical neoplasia
    Sung K Chang
    Electrical and Computer Engineering Department, University of Texas at Austin, 78712, USA
    IEEE Trans Biomed Eng 49:1102-11. 2002
    ..Similarly, large studies should be done in screening populations...
  87. ncbi request reprint Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV
    Martial Guillaud
    Department of Cancer Imaging, BC Cancer Agency, Vancouver, British Columbia, Canada
    Gynecol Oncol 99:S16-23. 2005
    ..In this report, we describe the results of an interim analysis of quantitative histopathology and chromatin texture as correlates of HPV infection using the cyto-savant system in cytologically and histopathologically negative specimens...
  88. ncbi request reprint Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma
    Andres G Chiesa-Vottero
    Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Int J Gynecol Pathol 26:328-33. 2007
    ..The overexpression of p16 in USC is unrelated to HPV. Further studies are necessary to determine whether p16 expression is useful in the differential diagnosis of ovarian high-grade serous carcinoma...
  89. ncbi request reprint Growing teratoma syndrome of the ovary: review of literature and first report of a carcinoid tumor arising in a growing teratoma of the ovary
    Bojana Djordjevic
    Department of Pathobiology and Laboratory Medicine, University of Toronto, Toronto, ON
    Am J Surg Pathol 31:1913-8. 2007
    ..This new information may help identify and screen women with germ cell tumors of the ovary at risk for GTS...
  90. ncbi request reprint An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms
    Ciaran J O'Neill
    Department of Pathology, Royal Group of Hospitals Trust, Belfast, Northern Ireland
    Am J Surg Pathol 29:1034-41. 2005
    ..In particular, the differences in p53 immunoreactivity are in keeping with the observation that p53 gene mutation is more common in high-grade than low-grade OSC...
  91. ncbi request reprint Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy
    Mary E Gordinier
    Program in Women s Oncology, Brown University Women and Infants Hospital, Providence, RI, USA
    Gynecol Oncol 90:625-8. 2003
    ..The objective of this study was to investigate the cause of groin recurrence in patients with vulvar cancer who had negative nodes in their superficial inguinal lymphadenectomy (SIL) specimens...
  92. ncbi request reprint Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary
    Jessica M Lopez
    Departamento de Patologia, Hospital de Clinicas Jose de San Martin, Buenos Aires, Argentina
    Ann Diagn Pathol 7:300-5. 2003
    ..After surgery, the patient received three cycles of chemotherapy. However, the disease progressed and the patient died 10 months after the diagnosis of the ovarian tumor...
  93. ncbi request reprint Tissue macroarray: a simple and cost-effective method for high-throughput studies
    Liang Wang
    Department of Pathology, The University of Texas Houston Medical School, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Appl Immunohistochem Mol Morphol 11:174-6. 2003
    ..This simple method does not need specialized equipment and should be an alternative efficient approach for large-scale clinical specimens...
  94. ncbi request reprint Conservative management of a uterine tumor resembling an ovarian sex cord-stromal tumor
    Jessica B Hillard
    Department of Obstetrics and Gynecology, University of Florida, Gainesville, FL 32607, USA
    Gynecol Oncol 92:347-52. 2004
    ..Only 55 cases have been reported thus far. A hysterectomy is typically recommended. We report a case of uterine tumor resembling an ovarian sex cord-stromal tumor managed conservatively...
  95. ncbi request reprint Metastatic tumors of the vulva: a clinicopathologic study of 66 cases
    Antonio G Neto
    Department of Pathology, University of Texas Medical School, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Am J Surg Pathol 27:799-804. 2003
    ..Metastatic tumors of the vulva are rare; however, the diagnosis of these tumors is facilitated by the knowledge of a preexistent malignancy and the lack of a mucocutaneous intraepithelial lesion...
  96. ncbi request reprint Detection of dysplasia with near real time confocal microscopy
    Anne Clark
    Department of Biomedical Engineering, University of Texas at Austin, Austin, Texas 78712, USA
    Biomed Sci Instrum 38:393-8. 2002
    ....